Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal of malignancies, in large measure, due to the propensity of PDAC cells to acquire resistance to chemotherapeutic agents. A better understanding of the molecular basis of acquired resistance is a major focus of contemporary PDAC resear...

Descripción completa

Detalles Bibliográficos
Autores principales: Mezencev, R, Matyunina, L V, Wagner, G T, McDonald, J F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159445/
https://www.ncbi.nlm.nih.gov/pubmed/27910856
http://dx.doi.org/10.1038/cgt.2016.71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159445/
https://www.ncbi.nlm.nih.gov/pubmed/27910856
http://dx.doi.org/10.1038/cgt.2016.71

Ejemplares similares